CClinicalTrials.gg
CompletedNCT05550311Updated Jan 29, 2024

Robot-Assisted Rehabilitation in Individuals With Stroke

An interventional study of Robot-assisted rehabilitation and Conventional rehabilitation in Stroke, sponsored by Biruni University. Completed at 1 site in Turkey. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-01-29.

Sponsored by Biruni University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
34
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Stroke has a high rate of morbidity and mortality worldwide. This disease is the third leading cause of death after ischemic heart disease and cancer. Stroke is also the leading cause of disability in adults. It is known that stroke individuals have not only limb restriction, but also respiratory capacity and exercise capacity. It has been shown in the literature that upper extremity functions are directly related to respiratory capacity. Although it is known that upper extremity training has positive effects on respiratory capacity in stroke individuals, more studies are needed to examine the effects of upper extremity robot-assisted rehabilitation on respiratory capacity. The aim of this study is to examine the effects of upper extremity robot-assisted rehabilitation applied in addition to conventional treatment on respiratory parameters, dyspnea, and functional capacity.

Read the detailed description

One of the most common complications in stroke patients is pulmonary aspiration and pneumonia, which are associated with respiratory functions being affected. Fluoroscopic examinations of stroke patients showed decreased movement in the diaphragm as well as in other muscles on the affected side. The combination of a decrease in respiratory parameters, weakness in respiratory muscles, and a decrease in diaphragmatic activity can cause dyspnea in individuals even that require minimal effort. The low level of physical activity is accompanied by a decrease in respiratory functions, and the participation of individuals in society decreases. The purpose of stroke rehabilitation is to reduce the complications caused by stroke and to increase the individual's psychological, social, physical, and professional level of independence and functionality to the highest level. Nowadays, stroke rehabilitation can be shaped by a variety of methods. In clinics, robotic rehabilitation is commonly used for stroke patients with the development of the technology. In the literature, studies show the effect of robotic rehabilitation on respiratory parameters, also robot-assisted walking training provides significant improvement in some respiratory parameters and increases aerobic capacity. The aim of this study is to evaluate the effects of upper extremity robot-assisted rehabilitation applied in addition to conventional treatment on respiratory parameters, dyspnea, and functional capacity in individuals with stroke.

02

Conditions studied

  • Stroke

Browse trials for

Keywords

  • robot-assisted training
  • respiratory parameters
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's enrollment of 34 is below the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Biruni University is the lead sponsor of 172 studies on the registry; 43 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Between the ages of 18-65,
  • Diagnosed with hemorrhagic or ischemic stroke,
  • Having a stroke history of at least 3 months,
  • Being 16 and above according to the Mini-Mental State Test,
  • Three and above according to the Brunnstrom stage,
  • Individuals not included in another rehabilitation program will be included.

Exclusion criteria

Exclusion Criteria:

  • Chronic cardiac or pulmonary diseases such as COPD, asthma, interstitial lung disease, and heart failure,
  • Using tobacco and tobacco products,
  • Severe spasticity to prevent robotic rehabilitation (on Modified Ashworth Scale,
  • With skin ulcers,
  • Non-union or unstable fracture status,
  • Individuals with pressure sores will not be included.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
34 participants (actual)

Study arms

  • Experimental
    Robot group

    In addition to conventional treatment, an upper extremity robot-assisted rehabilitation program will be applied for 45 minutes a day, two days a week.

    Other: Robot-assisted rehabilitation · Other: Conventional rehabilitation

  • Active comparator
    Control Group

    Participants in this group will be included in a conventional rehabilitation program

    Other: Conventional rehabilitation

Interventions

  • OtherRobot-assisted rehabilitation

    In addition to conventional treatment, an upper extremity robot-assisted rehabilitation program. Range of motion exercises will display on the monitor as a game form. There are 4 games available on the computer (airplane game, rabbit shooting game, ball game, and shopping game) and these games can provide exercises for three joints (shoulder, elbow wrist). There are also 3 different levels of resistance apparatus for each joint. People with a full range of motion can do these exercises with resistance. Before starting the rehabilitation, which joint and which movement to do is determined. To the person; After explaining the desired movement and how to play the game shown on the monitor, the exercises are started. The exercises last 45 minutes, during which exercises are performed for the shoulder, elbow, and wrist.

  • OtherConventional rehabilitation

    The conventional Rehabilitation Program consists of; range of motion exercises, strengthening exercises, stretching exercises, balance, and walking exercises and Bobath based neurophysiological approaches.

06

What researchers measure

Primary outcomes

  1. Forced expiratory volume 1. second (FEV1)/ Forced vital capacity (FVC) ratio

    Spirometric evaluation will be performed to determine the FEV1/FVC value of the participants.

    Time frame: Change from Baseline Forced expiratory volume 1. second (FEV1)/ Forced vital capacity (FVC) ratio at 6 weeks

  2. Maximal inspiratory pressure

    Mouth pressure will be assessed to document inspiratory muscle strength

    Time frame: Change from Baseline Maximal inspiratory pressure at 6 weeks

  3. Maximal expiratory pressure

    Mouth pressure will be assessed to document expiratory muscle strength

    Time frame: Change from Baseline Maximal expiratory pressure at 6 weeks

  4. Peak Expiratory Flow Rate

    Spirometric assessment will be performed to determine participants' peak expiratory flow rate.

    Time frame: Change from Baseline Peak Expiratory Flow Rate at 6 weeks

Secondary outcomes

  1. Peak cough flow

    Peak cough flow will be measured in triplicate during the "maximal coughing manoeuvre" with a digital PEFmeter.

    Time frame: Change from Baseline Peak cough flow at 6 weeks

  2. 6 Minutes Walking Test

    The 6 minutes walk test is a sub-maximal exercises test use to assess aerobic capacity and endurance.

    Time frame: Change from Baseline 6 Minutes Walking Test at 6 weeks

  3. Time Up and Go Test

    The test evaluates the dynamic balance and mobility.

    Time frame: Change from Baseline Time Up and Go Test at 6 weeks

  4. Dyspnea-12 Scale

    The dyspnea perception will be measured with this scale. There are 12 descriptor items on this scale ranging none (0), mild (1), moderate (2) or severe (3). It provides an overall score for breahtlessness severity that incorporates seven physical items and five affective items.

    Time frame: Change from Baseline Dyspnea-12 Scale at 6 weeks

  5. Satisfaction survey

    This text is used to assess patients' satisfaction. Evaluation will be scored between c0-5 as a verbal response. 0 = not at all satisfied, 5 = very satisfied.

    Time frame: At 6 weeks

07

Study locations

1 site
  • Biruni University
    Istanbul, 34010, Turkey
08

References and documents

Individual participant data

Plan to share: Undecided — The data will be shared during the publication process if the journal will ask.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 29, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05550311
Lead sponsor
Biruni University
Responsible party
Buket AKINCI (Assoc.Prof., Biruni University) — Principal investigator
First posted
Sep 22, 2022
Start date
Nov 15, 2022
Primary completion
Oct 1, 2023
Completion
Oct 15, 2023
Last update
Jan 29, 2024

Study contacts

Buket AKINCI, Assoc.Prof.
study chair · Biruni University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion